Peter Blume-Jensen, President and CEO at Acrivon Therapeutics, Inc. (ACRV), sold 14,036 shares at $2.21 ($31K) on 2026-08-25, disclosed to the SEC on 2026-08-27.
Open-market sale of $31k ACRV by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |